Diabetes drug kills cancer stem cells in combination treatment in mice
Monday, September 14, 2009 - 11:28
in Health & Medicine
PHILADELPHIA -- In a one-two punch, a familiar diabetes drug reduced tumors faster and prolonged remission in mice longer than chemotherapy alone by targeting cancer stem cells, Harvard Medical School researchers reported in the September 14 online first edition of Cancer Research, a journal of the American Association for Cancer Research.